Skip to main content
OpenTrials
Completed

NCT Number: NCT00637676

Tunneled Pleural Catheter in Partially Entrapped Lung

An open randomized, prospective, single center; parallel group trial to compare efficiency and safety of PleurX-Pleural Catheter versus standard surgical treatment in patients with malignant pleural effusion and partial entrapment of the lung.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Thoraxklinik, University of Heidelberg

Heidelberg, 69126, Germany

About this study

Patients with malignant pleural effusions undergo VATS-procedure. In the intraoperative finding of a partially entrapped lung, patients are randomized in 2 groups.

Arm 1: Insufflation of talc and insertion of a (standard) drainage which will be removed 4-7 days after surgery.

Arm 2: Insufflation of talc and insertion of a (standard) drainage which will be removed 4-7 days after surgery. Additionally, a subcutaneous tunneled catheter will be inserted and will remain in situ

Follow up period is 3 Months

Primary objective is the comparison of quality of life between the 2 arms.

Secondary objective is the reliability of the subcutaneous tunnelled catheter in practice as well as function and dysfunction of the drainage system. Clinical parameters (respiratory function measured as FEV1 and vital capacity, recurrent pleural effusion, infection, need for relief of effusion or pleuracentesis) are observed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • One-sided malignant pleural effusion, first occurrence, or following repeated pleuracentesis
  • History of dyspnea relieved after pleuracentesis
  • Patient is suitable for VATS
  • Surgery is indicated by diagnostic necessity
  • Ability of subject to understand character and individual consequences of clinical trial
  • Written informed consent must be available before enrolment in the trial
  • For women with childbearing potential, adequate contraception.
  • Histological proven pleural carcinosis by immediate sectioning
  • Intraoperative: partial entrapment of the lung

Exclusion criteria

  • Prior lobectomy or pneumonectomy on the affected side
  • The patient is not operable for general reasons or Karnofsky performance score < 50
  • Intraoperative suspicion of a pleural empyema
  • Chylothorax
  • Prior attempts at pleurodesis
  • Intended or prior intrapleural chemotherapy or radiotherapy
  • Pregnancy and lactation
  • Participation in other competing clinical trials and observation period of competing trials

Treatment and study plan

VATS, Talc-Pleurodesis, tunneled pleural drainage

Procedure

poudrage of 4 gr talc into the pleural cavity implantation of tunneled pleural catheter

Other names: Device: PleurX-Pleural Catheter

VATS, Talc-pleurodesis

Procedure

poudrage of 4 gr. talc into the pleural cavity no tunneled pleural catheter

Other names: no PleurX-Pleural Catheter

Primary outcomes

  1. global quality scale QL2

    Time frame: 3 months

Secondary outcomes

  1. clinical parameters (respiratory function measured as FEV1 and vital capacity, recurrent pleural effusion, infection, need for relief of effusion or pleuracentesis)

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Heidelberg University

Other

Registry information

Official study title

Randomized Trial of Tunneled Pleural Catheter Versus Standard Chest Tube in Management of Malignant Pleural Effusion in Patients With Partial Entrapment of the Lung

Important dates

Study start
2008
Primary completion
2011
Study completion
2011
First posted
Mar 18, 2008
Registry last updated
Sep 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.